[HTML][HTML] Deep learning techniques for cancer classification using microarray gene expression data

S Gupta, MK Gupta, M Shabaz, A Sharma - Frontiers in Physiology, 2022 - frontiersin.org
Cancer is one of the top causes of death globally. Recently, microarray gene expression
data has been used to aid in cancer's effective and early detection. The use of DNA …

[HTML][HTML] Using ncRNAs as tools in Cancer diagnosis and treatment—the way towards personalized medicine to improve patients' health

R Piergentili, G Basile, C Nocella, R Carnevale… - International journal of …, 2022 - mdpi.com
Although the first discovery of a non-coding RNA (ncRNA) dates back to 1958, only in recent
years has the complexity of the transcriptome started to be elucidated. However, its …

[HTML][HTML] Polymeric nanoparticles—Tools in a drug delivery system in selected cancer therapies

M Madej, N Kurowska, B Strzalka-Mrozik - Applied Sciences, 2022 - mdpi.com
The increase in cancer cases is undoubtedly affecting the development of new therapeutic
approaches. Polymeric nanoparticles are of great interest. Due to their relatively small size …

From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression

R Thapa, O Afzal, M Afzal, G Gupta, AA Bhat… - … -Research and Practice, 2023 - Elsevier
Cancer is a complex disease that causes abnormal genetic changes and unchecked cellular
growth. It also causes a disruption in the normal regulatory processes that leads to the …

From natural sources to synthetic derivatives: The allyl motif as a powerful tool for fragment-based design in cancer treatment

N Astrain-Redin, C Sanmartin… - Journal of Medicinal …, 2023 - ACS Publications
Since the beginning of history, natural products have been an abundant source of bioactive
molecules for the treatment of different diseases, including cancer. Many allyl derivatives …

[HTML][HTML] Therapeutic potential of tumor metabolic reprogramming in triple-negative breast cancer

G Munkácsy, L Santarpia, B Győrffy - International Journal of Molecular …, 2023 - mdpi.com
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with
clinical features of high metastatic potential, susceptibility to relapse, and poor prognosis …

[HTML][HTML] Unmet supportive care needs of breast cancer survivors: A systematic scoping review

R Fan, L Wang, X Bu, W Wang, J Zhu - BMC cancer, 2023 - Springer
Background Breast cancer is the most common type of cancer in women worldwide. Though
improved treatments and prolonged overall survival, breast cancer survivors (BCSs) …

[HTML][HTML] Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection

HS Tuli, VK Garg, S Bhushan, V Uttam, U Sharma… - Translational …, 2023 - Elsevier
Cancer prevalence and its rate of incidence are constantly rising since the past few
decades. Owing to the toxicity of present-day antineoplastic drugs, it is imperative to explore …

A truncated DNA aptamer with high selectivity for estrogen receptor-positive breast cancer cells

Y Cong, SY Zhang, HM Li, JJ Zhong, W Zhao… - International Journal of …, 2023 - Elsevier
The estrogen receptor-positive (ER+) breast cancers constitute more than 50% of breast
cancers, seriously threatening the health of women. Unfortunately, the detection and …

[HTML][HTML] Disulfidptosis-associated lncRNAs predict breast cancer subtypes

Q Xia, Q Yan, Z Wang, Q Huang, X Zheng, J Shen… - Scientific Reports, 2023 - nature.com
Disulfidptosis is a newly discovered mode of cell death. However, its relationship with breast
cancer subtypes remains unclear. In this study, we aimed to construct a disulfidptosis …